Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Pilocarpine for Xerostomia in Palliative Care
NCT05506137Phase 3Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Jan 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of pilocarpine in xerostomia (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Percentage of responders at 4 weeks. Status: unknown.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT05506137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05506137.